The FINANCIAL — Pfizer Inc. announced on September 24 that the company’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for ...
"This is an exciting milestone for women in the United Kingdom, and, potentially, in countries around the world, who might prefer this method of contraception and mode of administration." Pfizer Inc.
Seattle, April 12, 2018--Evidence published today on a new contraceptive option is providing one possible answer to an age-old question in family planning: how to address barriers that make it ...
Contraceptive injections are long-lasting forms of contraception, usually through the use of depot preparations of progestin medroxyprogesterone acetate (DMPA). They are touted to be highly effective ...
To compare longitudinal changes in weight, body fat, and ratio of central to peripheral fat mass among first-time depot-medroxyprogesterone acetate (DMPA) users to women using no hormonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results